Reuters logo
BRIEF-Lipocine announces financial and operational results for the first quarter 2017
May 8, 2017 / 12:22 PM / in 5 months

BRIEF-Lipocine announces financial and operational results for the first quarter 2017

May 8 (Reuters) - Lipocine Inc

* Lipocine announces financial and operational results for the first quarter 2017

* Q1 loss per share $0.26

* Q1 earnings per share view $-0.30 -- Thomson Reuters I/B/E/S

* Resubmission of new drug application for LPCN 1021 is planned for Q3 of 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below